SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062131
Filing Date
2023-11-09
Accepted
2023-11-09 16:30:31
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avro-20230930.htm   iXBRL 10-Q 2448606
2 EX-31.1 avro-ex31_1.htm EX-31.1 17613
3 EX-32.1 avro-ex32_1.htm EX-32.1 11394
  Complete submission text file 0000950170-23-062131.txt   8071236

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avro-20230930_def.xml EX-101.DEF 161864
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avro-20230930_lab.xml EX-101.LAB 422009
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avro-20230930.xsd EX-101.SCH 51786
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avro-20230930_cal.xml EX-101.CAL 34615
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avro-20230930_pre.xml EX-101.PRE 298052
64 EXTRACTED XBRL INSTANCE DOCUMENT avro-20230930_htm.xml XML 1356362
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 231393065
SIC: 2836 Biological Products, (No Diagnostic Substances)